Udokotela Omkhulu wasePeking University Cancer Hospital
USolwazi Zhitao Ying (MD)
●Okukhethekile: ukuxilongwa nokwelashwa kwe-lymphoma eyingozi, i-immunotherapy yamaselula.
●Ilungu leKomidi Lochwepheshe Abancane le-Chinese Society of Clinical Oncology (CSCO).
●Ilungu Elincane, Ikomidi Le-Hematologic Tumor, i-Chinese Anti-Cancer Association.
●Ilungu le-Chinese Geriatric Hematology Lymphoma Group.
●Ilungu LeKomidi Lochwepheshe Lokucwaninga Nokuhlola Kwezidakamizwa, Inhlangano YaseShayina Yokunakekelwa Kwezempilo Kwezempilo.
●Ukushicilelwa kwejenali: ngaphezu kwama-athikili angama-30 njengombhali wokuqala.
